Tag Archives: Diabetes

The “American Scientist” Magazine – November 2024

Current Issue

American Scientist (, 2024): The latest issue features ‘Slime Mold Beauty’ – A single-celled organism takes on a dazzling variety of glittering, jewlike forms…

The Myxomycetes: Nature’s Quick-Change Artists

Slime molds thrive in a range of environments, displaying an unexpected beauty in a variety of forms and life cycle stages.

Gliflozins for Diabetes: From Bark to Bench to Bedside

Drugs targeting the kidneys for diabetes treatment stem from almost two centuries of research that began with an uprooted apple orchard.

Baby Talk

Infants are born with the ability to babble and cry in the accents of their mothers through a combination of neurological, physical, and environmental responses.

Type 2 Diabetes Studies: 65% Higher Death Rates With ‘Sweetened Drinks’

Image

The BMJ (Published April 19, 2023) – Conclusions: Individual beverages showed divergent associations with all cause mortality and CVD outcomes among adults with type 2 diabetes. Higher intake of SSBs was associated with higher all cause mortality and CVD incidence and mortality, whereas intakes of coffee, tea, plain water, and low fat milk were inversely associated with all cause mortality. These findings emphasize the potential role of healthy choices of beverages in managing the risk of CVD and premature death overall in adults with type 2 diabetes.

READ COMPLETE BMJ RESEARCH STUDY

Healthy Aging: ‘Outlive – The Science And Art Of Longevity’ By Peter Attia

Trained as an oncological surgeon, Attia became interested in longevity because he saw that the “Four Horsemen” worked against it: diabetes, heart disease, cancer, and Alzheimer’s disease. All play a role in an unhealthy system, and all interrelate.

‘OUTLIVE – THE SCIENCE & ART OF LONGEVITY’ BY PETER ATTIA, MD

Outlive: The Science and Art of Longevity - Kindle edition by Attia MD,  Peter . Health, Fitness & Dieting Kindle eBooks @ Amazon.com.

A data- and anecdote-rich invitation to live better, and perhaps a little longer, by making scientifically smart choices.

If you have Type 2 diabetes, then your chances of developing heart disease, cancer, and neurological disorders increases, and if your goal is to live well in old age, then it behooves you to change your ways in order to keep your insulin reception levels in the clear. How to do so?

READ MORE AT KIRKUS REVIEWS

Opinion: China-US Danger Zone, Big Tech AI Race, Rice Fuels Diabetes Epidemic

April 3, 2023: A selection of three essential articles read aloud from the latest issue of The Economist. This week, the China-US contest is entering a new and more dangerous phase, how the tech giants are going all in on artificial intelligence (10:26) and why rice is fuelling climate change and diabetes (25:03).

Why the China-US contest is entering a new and more dangerous phase

Chinese officials rage at what they see as American bullying

Big tech and the pursuit of AI dominance

The tech giants are going all in on artificial intelligence. Each is doing it its own way

The global rice crisis

Rice feeds more than half the world—but also fuels diabetes and climate change

Heart Health: Cardiology Magazine – March 2023

Image

CARDIOLOGY MAGAZINE – MARCH 2023 ISSUE:

The Triple Whammy: Obesity, Diabetes and Sleep-Disordered Breathing and Their Impact on CVD

MARCH 2023

“It’s extremely important we as health care professionals address diabetes, poor sleep and poor sleep hygiene, and obesity as they are modifiable risk factors for cardiovascular disease,” says Nishant P. Shah, MD, FACC, a preventive cardiologist at Duke Heart Center, Duke University School of Medicine, in Durham, NC.

Obesity, diabetes and sleep-disordered breathing (SDB) are considered to be extant and growing public health crises. A wealth of information links these conditions to each other and to increased morbidity, reduced quality of life and death. While managing these conditions that often occur together may be challenging for patients and clinicians, successfully addressing them represents a real opportunity to reduce cardiovascular disease and prevent cardiovascular events.

READ CARDIOLOGY MAGAZINE DIGITAL ISSUE ONLINE

HEALTH: HOW CHRONIC KIDNEY DISEASE, DIABETES & HEART DISEASE ARE LINKED

Centers for Disease Control and Prevention (CDC) – The body is complicated! While organs in your body each have a specific job to do to keep you healthy, they still rely on each other to function well. When one organ isn’t working the way it should, it can put stress on other organs, causing them to stop working properly as well.

The relationship between chronic kidney disease (CKD), diabetes, and heart disease is one example of the ways our organs are connected.

The body uses a hormone called insulin to get blood sugar into the body’s cells to be used as energy. If someone has diabetes, their pancreas either doesn’t make enough insulin or can’t use the insulin it makes as well as it should.

If someone has CKD, their kidneys are not able to filter out toxins and waste from their blood as well as they should.

Heart disease refers to several types of heart conditions. The most common condition, coronary artery disease, leads to changes in blood flow to the heart, which can cause a heart attack.

Make the Connection

So how are these three conditions connected? Risk factors for each condition are similar and include high blood sugar, high blood pressure, family history, obesity, unhealthy diet, and physical inactivity.

High blood sugar can slowly damage the kidneys, and, over time, they can stop filtering blood as well as they should, leading to CKD. Approximately 1 in 3 adults with diabetes has CKD.

When the kidneys don’t work well, more stress is put on the heart. When someone has CKD, their heart needs to pump harder to get blood to the kidneys. This can lead to heart disease, the leading cause of death in the United States. Change in blood pressure is also a CKD complication that can lead to heart disease.

Luckily, preventing or managing one condition can help you prevent and manage the others and lower the risk for more complications.

Review: Abbott’s Discrete New Glucose Monitor

Abbott Laboratories newest continuous glucose monitor is now available at participating retail pharmacies and through durable medical equipment suppliers. The Freestyle Libre 3 was approved by the FDA in June and is a step up from previous Abbott systems.

Abbott Laboratories and Dexcom are the leaders in the CGM market, which hit $5.1 billion in revenue in 2021 and is expected to reach $13.2 billion by 2028, according to Vantage Market Research. Abbott’s CGM systems, called FreeStyle Libre, generated $3.7 billion in revenue last year, with 4 million users globally.

CNBC’s Erin Black, a type 1 diabetic, tested out the Libre 3 for over a month. Here is her review.

Reports: Tufts Health & Nutrition – October 2022

Cover Image

For Brain Health, Protect Your Heart

Are Your Sleep Habits Affecting Your Weight?

Eight Essentials for Heart Health

Food Processing and Your Health: Balancing Benefits and Risks

News Bites October 2022

Insights: The Lucrative Business Of Diabetes (2022)

In our modern consumer society, Type 2 diabetes has become a widespread disease. Companies are developing drugs that are increasingly expensive, but not necessarily more effective. Health authorities are powerless. Diabetes is spreading rapidly, all over the world. The disease destroys lives and puts a strain on public budgets.

The UN is calling on governments to take action. Diabetes is proof that modern societies are incapable of adequately treating chronic disease. It affects around 430 million people worldwide, with two main metabolic disorders falling under the name diabetes. Type 1 is an autoimmune disease that must be treated with lifelong doses of insulin, while type 2 can develop when a person’s diet is too high in fat and sugar and they do not engage in enough physical activity.

With turnover of $46 billion, diabetes is a massive and extremely lucrative market. Constantly promised miracle cures have not led to satisfactory treatment, with patients either taking too many drugs or no longer being able to afford them. It’s a desperate situation, and the only ones benefiting seem to be pharmaceutical companies. A medical focus on blood glucose levels has led to an overreliance on medication, sometimes without due concern for dangerous side effects.

Patients become trapped in a cycle of treatment, which in many cases still does not halt the disease’s progression. This can lead to amputations, blindness and heart attacks. And yet there are alternatives that could flatten the curve of the type 2 diabetes epidemic, while reducing health care spending. Improved diet can be a preventative measure, and a strict adherence to diet can also bring about remission in the case of Type 2 diabetes.

But these solutions require effort, as well as a complete rethinking of chronic disease management. Filmed on three continents, this documentary features industry whistleblowers, patients, researchers and medical professionals. It also confronts pharmaceutical companies about their responsibility for the situation.

Health: Consequences Of Too Little Sleep (Harvard)